Beijing Easpring Material Technology (300073.SZ) signed a long-term supply agreement with LG Energy Solution, Ltd.
When Techlong Inc. (300073.SZ) announced recently, the company and its subsidiary Jiangsu Techlong Material Technology Co., Ltd...
Beijing Easpring Material Technology (300073.SZ) announced that recently, the company and its subsidiaries, Jiangsu Dangsheng Material Technology Co., Ltd., Beijing Easpring Material Technology (Changzhou) Co., Ltd., and Beijing Easpring Material Technology (Finland) Co., Ltd. (collectively referred to as the "Seller"), signed a LONG TERM SUPPLY AGREEMENT with LG Energy Solution, Ltd. (referred to as "LGES" or "Buyer") in Seoul, South Korea. According to the agreement, LGES is expected to purchase 110,000 tons of high nickel and medium nickel lithium battery cathode materials and other models from Beijing Easpring Material Technology from 2025 to 2027. The specific order situation is subject to the actual execution.
 Related Articles 

Aurisco Pharmaceutical (605116.SH): Tian Tai Bo En plans to reduce its shareholding by no more than 0.25%.

Sichuan Kelun Pharmaceutical Co., Ltd. increased its stake in SSY GROUP (02005) by 1.128 million shares, with an estimated price of approximately 3.1 Hong Kong dollars per share.

Guangzhou Hexin Instrument (688622.SH): Kunshan Guoke intends to seek price inquiry for transferring 2% of the company's shares.
Aurisco Pharmaceutical (605116.SH): Tian Tai Bo En plans to reduce its shareholding by no more than 0.25%.

Sichuan Kelun Pharmaceutical Co., Ltd. increased its stake in SSY GROUP (02005) by 1.128 million shares, with an estimated price of approximately 3.1 Hong Kong dollars per share.

Guangzhou Hexin Instrument (688622.SH): Kunshan Guoke intends to seek price inquiry for transferring 2% of the company's shares.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


